FDAs Vision for Interactions with Counterpart Regulators around the World
|Event Date/Time: Nov 15, 2007|
The discovery, development, manufacturing, authorization, marketing, and use of pharmaceutical products have gone global. As a result, FDA has changed its approach to protecting and promoting public health. This new approach recognizes borders as boundaries, rather than as barriers to illness, product movement, and knowledge. As such, FDA interactions with global regulators continue to grow. This webinar will discuss FDA’s vision for continued interactions with counterpart regulators and how these new interactions will affect future decisions.